Mercy Research Joplin

Joplin, Missouri 64804

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Non Small Cell Lung Cancer Clinical Trial
QUILT-2.023: A Study of ALT-803, a Fusion Protein Activator of Natural Killer and T-Cells, in Combination With Pembrolizumab vs Pembrolizumab Alone as First-Line Treatment for Patients With Metastatic NSCLC.
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Research Joplin
mi
from
Joplin, MO
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Research Joplin
mi
from
Joplin, MO
Click here to add this to my saved trials